E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/4/2010 in the Prospect News Municipals Daily.

New Issue: Stanford Hospital and Clinics prices $233.765 million of refunding revenue bonds

By Sheri Kasprzak

New York, June 4 - The California Health Facilities Financing Authority priced on Friday $233.765 million of series 2010 refunding revenue bonds for Stanford Hospital and Clinics, said a pricing sheet.

The sale included $87.055 million of series 2010A bonds and $146.71 million of series 2010B bonds.

The 2010A bonds are due 2011 to 2021, with term bonds due 2025 and 2031. The coupons range from 4% to 5%. The 2025 bonds have a 5% coupon priced at 102.859. The 2031 bonds have a split maturity. One of the bonds has a 5.25% coupon priced at 102.823. The other bonds have a 5.75% coupon priced at 108.135.

The 2010B bonds are due 2025, 2031 and 2036. The 2025 and 2031 bonds have split maturities. One of the 2025 bonds has a 4.5% coupon priced at 98.358, and the other has a 5% coupon priced at 102.859. The 2031 bonds have a 5.25% coupon priced at 102.823, and a 5.75% coupon priced at 108.135. The 2036 bonds have a 5% coupon priced at 98.553.

The bonds (Aa3/A+/AA-) were sold through Morgan Stanley & Co. Inc. with J.P. Morgan Securities Inc. and Goldman, Sachs & Co. as the co-managers.

Proceeds will be used to refund the hospital's series 1998B and 2003B-D bonds, which were used to construct, equip and renovate Stanford Hospital and Clinics facilities.

The Sacramento-based authority provides financing for health care facilities throughout the state.

Issuer:California Health Facilities Financing Authority/Stanford Hospital and Clinics
Issue:Series 2010 refunding revenue bonds
Amount:$233.765 million
Type:Negotiated
Underwriters:Morgan Stanley & Co. Inc. (lead), J.P. Morgan Securities Inc. and Goldman, Sachs & Co. (co-managers)
Ratings:Moody's: Aa3
Standard & Poor's: A+
Fitch: AA-
Pricing date:June 4
Settlement date:June 16
Series 2010A
MaturityTypeCouponPrice
2011Serial4%104.129
2012Serial5%108.39
2013Serial4%107.046
2014Serial5%111.492
2015Serial4%106.974
2016Serial5%111.588
2017Serial5%111.236
2018Serial5%111.079
2019Serial5%110.503
2020Serial5%109.877
2021Serial5%108.712
2025Term5%102.859
2031Term5.25%102.823
2031Term5.75%108.135
Series 2010B
MaturityTypeCouponPrice
2025Term4.5%98.358
2025Term5%102.859
2031Term5.25%102.823
2031Term5.75%108.135
2036Term5%98.553

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.